IMVT: Immunovant, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 4,143.76
Enterprise Value ($M) 3,452.82
Book Value ($M) 679.34
Book Value / Share 4.68
Price / Book 6.10
NCAV ($M) 678.67
NCAV / Share 4.67
Price / NCAV 6.11

Profitability (mra)
Return on Invested Capital (ROIC) -0.36
Return on Assets (ROA) -0.60
Return on Equity (ROE) -0.67

Liquidity (mrq)
Quick Ratio 22.14
Current Ratio 22.14

Balance Sheet (mrq) ($M)
Current Assets 710.78
Assets 711.45
Liabilities 32.10
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Non Redeemable Common Stock Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Deep Track Capital, LP 0.69 -89.70
02-09 13G Fmr Llc 5.44
10-04 13D/A Roivant Sciences Ltd. 55.30 8.74

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-02 84,946 602,724 14.09
2024-05-01 190,690 996,899 19.13
2024-04-30 169,273 932,060 18.16
2024-04-29 258,618 502,434 51.47

(click for more detail)

Similar Companies
IFRX – InflaRx N.V. IGMS – IGM Biosciences, Inc.
IMUX – Immunic, Inc. INDV – Indivior PLC
INNV – InnovAge Holding Corp.


Financial data and stock pages provided by
Fintel.io